FDA Drug Shortages — Page 29
Browse FDA drug shortages by generic name, company and status, with first-posted dates, from the FDA drug shortage database. RegDataLab tracks 1,814 drug shortages from official FDA sources, updated on an ongoing basis.
| Drug shortages | Details |
|---|---|
| Metronidazole Injection | Current — Gland Pharma Limited |
| Fentanyl Citrate Injection | Current — Hikma Pharmaceuticals USA, Inc. |
| Obeticholic Acid Tablet | No longer listed by FDA — Intercept Pharmaceuticals |
| Fondaparinux Sodium Injection | No longer listed by FDA — Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.) |
| Insulin Lispro-aabc Injection | No longer listed by FDA — Eli Lilly And Co. |
| Ropivacaine Hydrochloride Injection | Current — Eugia US LLC |
| Ketorolac Tromethamine Injection | No longer listed by FDA — Gland Pharma Limited |
| Morphine Sulfate Injection | Current — Hospira, Inc., A Pfizer Company |
| Morphine Sulfate Injection | Current — Hikma Pharmaceuticals USA, Inc. |
| Ropivacaine Hydrochloride Injection | Current — Caplin Steriles, Ltd. |
| Dopamine Hydrochloride Injection | Current — Hikma Pharmaceuticals USA, Inc. |
| Bumetanide Injection | Resolved — Hikma Pharmaceuticals USA, Inc. |
| Oseltamivir Phosphate Capsule | No longer listed by FDA — Genentech, Inc |
| Naltrexone Hydrochloride Tablet | No longer listed by FDA — Accord Healthcare Inc. |
| Carboplatin Injection | Current — Hospira, Inc., A Pfizer Company |
| Sodium Bicarbonate Injection | No longer listed by FDA — Hospira, Inc., A Pfizer Company |
| Dextrose Monohydrate 5% Injection | Current — B. Braun Medical Inc. |
| Ropivacaine Hydrochloride Injection | Current — Fresenius Kabi USA, LLC |
| Sterile Water Irrigant | Current — B. Braun Medical Inc. |
| Levothyroxine Sodium Tablet | No longer listed by FDA — EMD Serono, Inc. |
| Azacitidine Injection | Current — Accord Healthcare Inc. |
| Morphine Sulfate Injection | Current — Fresenius Kabi USA, LLC |
| Dextrose Monohydrate 5% Injection | Current — Baxter Healthcare |
| Dextrose Monohydrate 10% Injection | Current — B. Braun Medical Inc. |
| Bupivacaine Hydrochloride Injection | No longer listed by FDA — Hospira, Inc., A Pfizer Company |
| Rocuronium Bromide Injection | Current — Piramal Critical Care Inc. |
| Ropivacaine Hydrochloride Injection | Current — Fresenius Kabi USA, LLC |
| Ketorolac Tromethamine Injection | Current — Hikma Pharmaceuticals USA, Inc. |
| Dexmedetomidine Hydrochloride Injection | Current — Gland Pharma Limited |
| Triamcinolone Acetonide Injection | Resolved — Harrow Eye, LLC |
| Epinephrine Bitartrate, Lidocaine Hydrochloride Injection | Current — Hospira, Inc., A Pfizer Company |
| Palonosetron Hydrochloride Injection | To Be Discontinued — Teva Pharmaceuticals USA, Inc. |
| Hydromorphone Hydrochloride Injection | Current — Hikma Pharmaceuticals USA, Inc. |
| Levothyroxine Sodium Tablet | No longer listed by FDA — EMD Serono, Inc. |
| Desmopressin Acetate Spray | Current — Apotex Corp. |
| Dexmedetomidine Hydrochloride Injection | Current — Baxter Healthcare |
| Quinapril Hydrochloride Tablet | Current — Lupin Pharmaceuticals, Inc. |
| Amino Acid Injection | Current — Baxter Healthcare |
| Riluzole Oral Suspension | Current — EDW Pharma, Inc. (Formerly Italfarmaco Pharma, Inc.) |
| Rocuronium Bromide Injection | Current — Sandoz Inc. |
| Clindamycin Phosphate Injection | Current — Baxter Healthcare |
| Furosemide Injection | Current — Meitheal Pharmaceuticals, Inc. |
| Lidocaine Hydrochloride Injection | Current — Hospira, Inc., A Pfizer Company |
| Lisdexamfetamine Dimesylate Tablet, Chewable | Current — Takeda Pharmaceuticals USA Inc. |
| Hydromorphone Hydrochloride Injection | Current — Teva Pharmaceuticals USA, Inc. |
| Levothyroxine Sodium Tablet | No longer listed by FDA — EMD Serono, Inc. |
| Promethazine Hydrochloride Injection | Current — XGen Pharmaceuticals DJB, Inc. |
| Lisdexamfetamine Dimesylate Capsule | Current — Rhodes Pharmaceuticals L.P. |
| Desmopressin Acetate Spray | Current — Ferring |
| Methylphenidate Film, Extended Release | Current — Noven Pharmaceuticals, Inc. |